Applied Cells published an application note detailing automated CD14+ isolation on MARS Bar, workflow overview, recovery and purity data, viability assessment, and downstream differentiation into dendritic cell and macrophage-like phenotypes.
Published
Signal category
Research & Knowledge
Quote
“Inside the application note: automated CD14+ isolation on MARS® Bar, workflow overview, recovery and purity data, viability assessment, and downstream differentiation into dendritic cell and macrophage-like phenotypes”
— Applied Cells team
Company
Applied Cells
Supporting life science experts across the globe with Cell Separation solutions for #CellTherapy and #TumorDetection.
- Industry
- Biotechnology Research
- Location
- Santa Clara, US
- Company size
- 11 employees
Discover MARS Bar and our GoFast™ workflow, innovative cell separation and manufacturing solutions that combine advanced instrumentation with validated reagents and protocols. We empower innovators to develop next-generation cell therapies through faster, simpler, and scalable processes. With a mission to drive COGS below $10K and global access, we are contributing to building the future of affordable, life-saving cell therapy worldwide.
Founded 2018